Our work gets us noticed. UBMD physicians make headlines for raising the bar on clinical care, leading community health initatives and conducting groundbreaking research, among other advancements and accomplishments.
Updated results from a phase 3 clinical trial are expected to change the way advanced stage classic Hodgkin lymphoma is treated in newly diagnosed adolescents and adults.
UB's new Aging and Resilience Research Center on The Brothers of Mercy Wellness Campus in Clarence, N.Y. is dedicated to identifying the factors that contribute to healthy, resilient aging.
L. Nelson “Nick” Hopkins, MD, SUNY Distinguished Professor and a neurosurgeon best known for changing the way stroke patients are treated, died Oct. 5. He was 81.
Elad Levy will present results of the clinical trial that assessed the safety of Synchron’s endovascular brain-computer interface in people with severe paralysis at the Congress of Neurological Surgeons (CNS).
UB research has identified the genetic elements responsible for turning classical Klebsiella pneumoniae into a hypervirulent version, which can infect otherwise healthy people in the community.
A UB psychiatrist who has played a critical role in getting mental health screening and treatment integrated into routine care for cystic fibrosis (CF) has been awarded $3 million from the Cystic Fibrosis Foundation to focus on the mental health of children with the disease.
Daniel Woo, MD, professor of neurology and rehabilitation medicine in the University of Cincinnati College of Medicine, has been appointed the Irvin and Rosemary Smith Endowed Chair of the Department of Neurology.
